Article
Advances in the genetics of schizophrenia: toward a network and pathway view for drug discovery.
Annals of the New York Academy of Sciences - 1 Feb 2016
Collier David A, Eastwood Brian J, Malki Karim, Mokrab Younes
Abstract excerpt
The spectacular advance in our understanding of the genetic basis of schizophrenia through genome-wide association studies has the potential to identify new leads for drug treatment through improved understanding of disease pathophysiology. However, using these genetic associations successfully in drug development and patient stratification requires further target validation, particularly in understanding which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
